Kamada VP discloses stock option holdings

Kamada Ltd executive Reshef Liron, VP Human Resources, filed an initial ownership report showing holdings of stock options on the company’s ordinary shares.

Rhea-AI Filing Summary

Kamada Ltd executive Reshef Liron, VP Human Resources, filed an initial ownership report showing holdings of stock options on the company’s ordinary shares. The options are exercisable using a net-exercise method and their exercise prices in U.S. dollars reflect a translation from NIS as of March 13, 2026.

The holdings include option tranches for 10,000 ordinary shares at an exercise price of $5.33 per share expiring in 2029, and tranches for 15,000 ordinary shares at an exercise price of $7.55 per share expiring in 2035, all held directly.

Insider Trade Summary

8 transactions reported

Mixed 8 txns

Insider Reshef Liron

Role VP Human Resources

Type	Security	Shares	Price	Value
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--

Holdings After Transaction: Options to purchase Ordinary Shares — 100,000 contracts (Direct)

Footnotes (2)

1. F1. These options to purchase ordinary shares are exercisable using a net-exercise method
2. F2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Kamada (KMDA) VP Reshef Liron report in this Form 3?

The filing shows VP Human Resources Reshef Liron reporting his initial beneficial ownership in Kamada Ltd through stock options on ordinary shares, detailing the option amounts, exercise prices, expiration dates, and that the options are held directly.

What stock options does Kamada (KMDA) VP Reshef Liron hold?

He holds options to purchase ordinary shares, including tranches for 10,000 shares at a $5.33 exercise price expiring in 2029 and tranches for 15,000 shares at a $7.55 exercise price expiring in 2035, all directly held.

How are the exercise prices for Kamada (KMDA) options translated in this filing?

The exercise prices in U.S. dollars are a convenience translation from NIS, based on the representative exchange rate of the Bank of Israel as of March 13, 2026, according to the footnote in the ownership report.

What exercise method applies to Kamada (KMDA) VP Reshef Liron’s options?

The options to purchase Kamada ordinary shares are exercisable using a net-exercise method, meaning the holder receives shares net of the value used to pay the exercise price rather than paying cash upfront for all underlying shares.

Are Kamada (KMDA) VP Reshef Liron’s reported option holdings direct or indirect?

All reported option positions are shown as direct holdings. The ownership code is listed as “D”, and no nature-of-ownership footnote indicates any trust, partnership, or other indirect holding structure for these options.

Does this Kamada (KMDA) Form 3 show any stock purchases or sales?

No purchases or sales are indicated. The entries are labeled as holdings of options, with the transaction summary showing zero buy and sell counts and categorizing the records as unknown-direction transactions rather than new market trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 07:02 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Reshef Liron

(Last) (First) (Middle)

13 RIMON

(Street)

MOSHAV GEALIA L3 7688500

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Human Resources

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase Ordinary Shares(1)	03/02/2024	09/02/2029	Ordinary Shares	10,000	$5.33(2)	D
Options to purchase Ordinary Shares(1)	03/02/2025	09/02/2029	Ordinary Shares	10,000	$5.33(2)	D
Options to purchase Ordinary Shares(1)	03/02/2026	09/02/2029	Ordinary Shares	10,000	$5.33(2)	D
Options to purchase Ordinary Shares(1)	10/22/2026	10/22/2035	Ordinary Shares	15,000	$7.55(2)	D
Options to purchase Ordinary Shares(1)	03/02/2027	09/02/2029	Ordinary Shares	10,000	$5.33(2)	D
Options to purchase Ordinary Shares(1)	10/22/2027	10/22/2035	Ordinary Shares	15,000	$7.55(2)	D
Options to purchase Ordinary Shares(1)	10/22/2028	10/22/2035	Ordinary Shares	15,000	$7.55(2)	D
Options to purchase Ordinary Shares(1)	10/22/2029	10/22/2035	Ordinary Shares	15,000	$7.55(2)	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Liron Reshef	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.